Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer
This study has been terminated.
(Sponsor proceeded with a phase III study for same indication.)
Sponsor:
NewLink Genetics Corporation
Information provided by (Responsible Party):
NewLink Genetics Corporation
ClinicalTrials.gov Identifier:
NCT00614601
First received: January 31, 2008
Last updated: September 19, 2011
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | September 2012 |
| Estimated Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |